Fig. 2

CONSORT flow chart. Four patients were excluded from the final analysis: two patients belonged to the PACK-CXL arm and needed additional antimicrobial therapy, one patient in the control group (medication only) presented with a perforation on day 7 after initiation of therapy and another patient in the control group required therapeutic keratoplasty